Skip to main content

Table 1 Clinical features of MOG 35-55 -immunized mice treated with mepazine or vehicle

From: Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis

Treatment

Incidence

Day of disease onseta

Mean maximal clinical scorea

Vehicle

100% (8/8)

16.6 ± 0.9

3.8 ± 0.3

Mepazine

33% (3/10)

16.3 ± 1.3

2.1 ± 0.4b

  1. aResults are displayed as mean ± SEM.
  2. b P <0.01.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094